Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Concord Medical Services ( (CCM) ) just unveiled an announcement.
Concord Healthcare, a subsidiary of Concord Medical Services Holdings Limited, announced its interim results for the first half of 2025 on August 28, 2025. The announcement follows the listing of Concord Healthcare’s H shares on the Hong Kong Stock Exchange in January 2024, indicating a strategic move to enhance its market presence and financial transparency.
The most recent analyst rating on (CCM) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Concord Medical Services stock, see the CCM Stock Forecast page.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Neutral.
Concord Medical Services is facing significant financial challenges, with persistent losses and high leverage being the most critical factors. The technical analysis suggests bearish momentum, and the negative P/E ratio highlights valuation concerns. The absence of earnings call data and corporate events does not alter the overall negative outlook.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited operates in the healthcare industry, focusing on providing medical services. It is involved in the management and operation of radiotherapy and diagnostic imaging centers and is listed on the New York Stock Exchange under the ticker CCM.
Average Trading Volume: 10,389
Technical Sentiment Signal: Strong Sell
Current Market Cap: $24.51M
For an in-depth examination of CCM stock, go to TipRanks’ Overview page.